Page 4 - பெருநிறுவன தகவல்தொடர்புகள் முதலீட்டாளர் உறவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cytokinetics Announces Pricing of Public Offering of Common Stock July 20, 2021 23:15 ET | Source: Cytokinetics, Incorporated Cytokinetics, Incorporated South San Francisco, California, UNITED STATES SOUTH SAN FRANCISCO, Calif., July 20, 2021 (GLOBE NEWSWIRE) Cytokinetics, Incorporated (Nasdaq:CYTK) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $27.50 per share, before underwriting discounts and commissions. The gross proceeds to Cytokinetics from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Cytokinetics, are expected to be $275 million. The offering is expected to close on July 23, 2021, subject to customary closing conditions. Additionally, Cytokinetics has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of its common stock at the publi

New yorkUnited statesDiane weiserMorgan stanleyBroadridge financial solutionsJp morgan securitiesCorporate communications investor relationsNeedham companyExchange commissionCytokinetics incorporated nasdaqProspectus departmentHc wainwright coMorgan stanley coIsland avenueCytokinetic quarterly reportVice president